Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section now includes Florida; 'Florida Locations' has been removed and the page revision updated to v3.3.3, with the HHS Vulnerability Disclosure link removed.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedMinor site revision labels updated: added Revision: v3.3.2 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedDifference0.5%

- Check91 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

- Check98 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.